Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eastman Chemical (EMN) Total Current Liabilities (2016 - 2026)

Eastman Chemical (EMN) has disclosed Total Current Liabilities for 18 consecutive years, with $2.8 billion as the latest value for Q1 2026.

  • For Q1 2026, Total Current Liabilities rose 21.99% year-over-year to $2.8 billion; the TTM value through Mar 2026 reached $2.8 billion, up 21.99%, while the annual FY2025 figure was $2.7 billion, 2.07% down from the prior year.
  • Total Current Liabilities hit $2.8 billion in Q1 2026 for Eastman Chemical, up from $2.7 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $3.3 billion in Q4 2022 and bottomed at $2.2 billion in Q3 2025.
  • Average Total Current Liabilities over 5 years is $2.7 billion, with a median of $2.7 billion recorded in 2024.
  • Year-over-year, Total Current Liabilities soared 55.56% in 2022 and then fell 20.76% in 2023.
  • Eastman Chemical's Total Current Liabilities stood at $3.3 billion in 2022, then decreased by 20.76% to $2.6 billion in 2023, then grew by 5.12% to $2.7 billion in 2024, then fell by 2.07% to $2.7 billion in 2025, then increased by 4.37% to $2.8 billion in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $2.8 billion, $2.7 billion, and $2.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.